Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 19, 2018 - Issue 15
Submit an article Journal homepage
270
Views
8
CrossRef citations to date
0
Altmetric
Review

Current developments in pharmacotherapy for actinic keratosis

Elena CampioneDermatology Clinic, University of Rome Tor Vergata, ItalyCorrespondence[email protected]
View further author information
,
Alessandra VenturaDermatology Clinic, University of Rome Tor Vergata, ItalyView further author information
,
Laura DiluvioDermatology Clinic, University of Rome Tor Vergata, ItalyView further author information
,
Mauro MazzeoDermatology Clinic, University of Rome Tor Vergata, ItalyView further author information
,
Sara MazzilliDermatology Clinic, University of Rome Tor Vergata, ItalyView further author information
,
Virginia GarofaloDermatology Clinic, University of Rome Tor Vergata, ItalyView further author information
,
Monia Di PreteDepartment of Anatomic Pathology, University of Rome Tor Vergata, ItalyView further author information
&
Luca BianchiDermatology Clinic, University of Rome Tor Vergata, ItalyView further author information
 show all
Pages 1693-1704 | Received 24 Apr 2018, Accepted 11 Sep 2018, Published online: 09 Oct 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Virginia Garofalo, Francesco Geraci, Monia Di Prete, Caterina Lanna, Flavia Lozzi, Terenzio Cosio, Sara Lambiase, Ruslana Gaeta Shumak, Cosimo Di Raimondo, Laura Diluvio, Luca Bianchi & Elena Campione. (2022) Early clinical response to 5-fluorouracil 0.5% and salicylic acid 10% topical solution in the treatment of actinic keratoses of the head: an observational study. Journal of Dermatological Treatment 33:5, pages 2664-2669.
Read now
Flavia Lozzi, Caterina Lanna, Mauro Mazzeo, Virginia Garofalo, Vincenzo Palumbo, Sara Mazzilli, Laura Diluvio, Alessandro Terrinoni, Luca Bianchi & Elena Campione. (2019) Investigational drugs currently in phase II clinical trials for actinic keratosis. Expert Opinion on Investigational Drugs 28:7, pages 629-642.
Read now

Articles from other publishers (6)

Alise Balcere, Māris Sperga, Ingrīda Čēma, Gunārs Lauskis, Maksims Zolovs, Māra Rone Kupfere & Angelika Krūmiņa. (2023) Expression of p53, p63, p16, Ki67, Cyclin D, Bcl-2, and CD31 Markers in Actinic Keratosis, In Situ Squamous Cell Carcinoma and Normal Sun-Exposed Skin of Elderly Patients. Journal of Clinical Medicine 12:23, pages 7291.
Crossref
Jon Chim Bai‐Habelski, Annette Ko, Christoph Ortland, Marcus Stocker, Andrea Ebeling & Uwe Reinhold. (2022) 5‐ALA loaded self‐adhesive patch‐PDT is effective and safe in the treatment of actinic keratoses on hands and arms . Experimental Dermatology 31:9, pages 1385-1391.
Crossref
Carla Prezioso, Gabriele Brazzini, Sara Passerini, Carlotta Di Fabio, Terenzio Cosio, Sergio Bernardini, Elena Campione, Ugo Moens, Valeria Pietropaolo & Marco Ciotti. (2022) Prevalence of MCPyV, HPyV6, HPyV7 and TSPyV in Actinic Keratosis Biopsy Specimens. Viruses 14:2, pages 427.
Crossref
Zafer Sattouf, Steven J. Repas, Jeffrey B. Travers & Craig A. Rohan. (2021) Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches. Journal of Skin Cancer 2021, pages 1-12.
Crossref
Roy Chen, Jeffrey J. Wargo, Amy Williams, Elizabeth Cates, Dan F. Spandau, Christina Knisely & Jeffrey B. Travers. (2019) Single Ablative Fractional Resurfacing Laser Treatment For Forearm Actinic Keratoses: 6‐Month Follow‐Up Data From An Intrapatient Comparison Between Treated and Untreated Sites. Lasers in Surgery and Medicine 52:1, pages 84-87.
Crossref
Alisen Huang, Julie K. Nguyen, Evan Austin, Andrew Mamalis & Jared Jagdeo. (2019) Updates on Treatment Approaches for Cutaneous Field Cancerization. Current Dermatology Reports 8:3, pages 122-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.